Clinical Trial Detail

NCT ID NCT03568058
Title Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ezra Cohen
Indications

Advanced Solid Tumor

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.